Increasing Patient Safety Among Multiple Sclerosis (MS) Drug Dalfampridine Users by Expanding Awareness of the Serious Side Effects

Dalfampridine is a drug used to improve walking in multiple sclerosis (MS) patients. Approved in 2010, it is contraindicated in patients who have a history of seizures and/or renal disease. In this case report, we present a patient who did not have either of these contraindications yet had a seizure...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaman, Rameez, Goldberg, Elliott, Zomorodi, Naseem, Acharya, Vinita J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Emergency Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808083/
https://www.ncbi.nlm.nih.gov/pubmed/35145789
http://dx.doi.org/10.7759/cureus.20884

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808083/
https://www.ncbi.nlm.nih.gov/pubmed/35145789
http://dx.doi.org/10.7759/cureus.20884

Ejemplares similares